Area of research
Orthopedics and Sports Medicine · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Medicine, Internal medicine, Type 2 diabetes, Endocrinology, Wnt signaling pathway, and Coronavirus disease 2019 (COVID-19).
Bone inflammation in postmenopausal women with type 2 diabetes or obesity in relation to Wnt signaling and bone strength
The role of oxidative post-translational modifications in type 1 diabetes pathogenesis
Fibre‐Enriched High‐Carbohydrate (FEHC) Diet Modulates Inflammation Without Affecting Bone Health in Older Women With Obesity: A Randomised Clinical Trial
Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength
More Rapid Bone Mineral Density Loss in Older Men With Diabetes: The Osteoporotic Fractures in Men (MrOS) Study
Targeting the Hallmarks of Aging with Vitamin D: Starting to Decode the Myth
The Mediating Role of Kynurenine Pathway Metabolites on the Relationship Between Inflammation and Muscle Mass in Oldest–Old Men
Targeting the Hallmarks of Aging with Vitamin D: Starting to Decode the Myth
Increased bone inflammation in type 2 diabetes and obesity correlates with Wnt signaling downregulation and reduced bone strength
Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher Advanced Glycation End-products (AGEs) content and reduced bone strength
Author Response: Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher Advanced Glycation End-products (AGEs) content and reduced bone strength
Author response: Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength
Increased bone inflammation in type 2 diabetes and obesity correlates with Wnt signaling downregulation and reduced bone strength
Increased bone inflammation in type 2 diabetes and obesity correlates with Wnt signaling downregulation and reduced bone strength
Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength
Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The <scp>IMDIAB</scp> 25 years follow‐up study
Prevaccination Glucose Time in Range Correlates With Antibody Response to SARS-CoV-2 Vaccine in Type 1 Diabetes
Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher Advanced Glycation End-products (AGEs) content and reduced bone strength
Abdominal adipose tissue distribution assessed by computed tomography and mortality in hospitalised patients with COVID-19: a retrospective longitudinal cohort study
Abdominal adipose tissue distribution assessed by computed tomography and mortality in hospitalised patients with COVID-19
Wnt Signaling Regulation in Bone of Postmenopausal Women With Type 2 Diabetes
Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis
Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
Vertebral fractures and mortality risk in hospitalised patients during the COVID-19 pandemic emergency
Bone fragility in patients with diabetes mellitus: A consensus statement from the working group of the Italian Diabetes Society (SID), Italian Society of Endocrinology (SIE), Italian Society of Gerontology and Geriatrics (SIGG), Italian Society of Orthopaedics and Traumatology (SIOT)
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity
Secondary prevention of fragility fractures: where do we stand during the COVID-19 pandemic?
Letter to the Editor From Viola et al: “Calcifediol Treatment and COVID-19-Related Outcomes”
Letter to the Editor from Viola et al.: “Diminishing Value from Multiple Serial Bone Densitometry in Women Receiving Antiresorptive Medication for Osteoporosis”